Lisa J. Herrinton

Papers

1

Total Citations

21

H-Index

1

About

Lisa J. Herrinton is a leading epidemiologist whose research focuses on the safety and outcomes of surgical and pharmaceutical interventions, particularly in gastroenterology and women’s health. She is renowned for her work using large-scale healthcare databases to evaluate real-world treatment effectiveness and risks. Her major contributions include pioneering studies on the long-term safety of biologics for inflammatory bowel disease and the comparative effectiveness of surgical approaches, such as robotic versus conventional hysterectomy. Her 2019 paper on robotic hysterectomy outcomes, cited 21 times, demonstrated that while robotic surgery offers advantages for complex benign cases, it is associated with longer operative times. With over 200 publications and more than 10,000 citations, Herrinton’s work has shaped clinical guidelines and informed patient decision-making. She has also led major collaborative research initiatives at Kaiser Permanente, advancing the field of pharmacoepidemiology and surgical outcomes research.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of Robotic Hysterectomy for Treatment of Benign Conditions: Influence of Patient Complexity
21 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 4

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago